Showing results (101-110 of 186) with videos related to
Sort By:
Pageof 19
Leukemia & Lymphoma|August 26, 2020
Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignanciesYaogong Wu, Wenlan Chen, Wenjing Li, et al.Critical Reviews in Oncology/Hematology|October 10, 2025
Comparison of regional differences in safety and efficacy of CAR-T therapy for hematologic malignancies in a real-world setting: a systematic review and meta-analysisZhihan Chen, Wenjng Luo, Yun Kang, et al.Haematologica|February 1, 2024
GPIbα CAAR T cells function like a Trojan horse to eliminate autoreactive B cells to treat immune thrombocytopeniaJie Zhou, Yanyan Xu, Jinhui Shu, et al.BMC Cancer|August 30, 2019
Comparative efficacy and tolerability of front-line treatments for newly diagnosed chronic-phase chronic myeloid leukemia: an update network meta-analysisLu Tang, Huan Zhang, Yi-Zhong Peng, et al.Cancer Science|June 17, 2025
Selinexor Reduces the Immunosuppression of Macrophages and Synergizes With CD19 CAR-T Cells Against B-Cell LymphomaWenjing Luo, Jia Xu, Chenggong Li, et al.Frontiers in Immunology|July 8, 2022
Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic LeukemiaYinqiang Zhang, Fen Zhou, Zhuolin Wu, et al.The Journal of Allergy and Clinical Immunology. in Practice|November 7, 2020
Predictive Nomogram for Severe COVID-19 and Identification of Mortality-Related Immune FeaturesLi Cai, Xi Zhou, Miao Wang, et al.International Journal of Biological Macromolecules|May 25, 2024
Indocyanine green-mediated fabrication of urchin-like hydroxyethyl starch nanocarriers for enhanced drug tumor EPR and deep penetration effectsYuxiang Tang, Zeliang Wu, Hang Hu, et al.Frontiers in Oncology|November 26, 2020
Tissue Factor-Targeted "O<sub>2</sub>-Evolving" Nanoparticles for Photodynamic Therapy in Malignant LymphomaZiying Li, Yanxue Yin, Weiwei Jin, et al.Biomaterials|September 7, 2013
LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain gliomaBo Zhang, Xiyang Sun, Heng Mei, et al.Pageof 19